403. Can BioTech Extend Life to 150 Years? Gene Editing, and Investing in the Future of Life Sciences (Risa Stack)

472. DeepSeek’s Impact on Other LLMs, AI’s Effect on Software Engineering, Nvidia’s Future, and the Next Wave of Developer-First Companies (Joseph Ruscio)

Investor Stories 390: Visionary Founders (Roizen, Boduch, Ho)

471. How AI Transforms Services into Software and Revolutionizes Enterprise SaaS (Shashank Saxena)

Investor Stories 389: Best LP Question (von Tobel, Felesky, Patil)

470. The Former CTO of Meta on DeepSeek, Lessons from Zuckerberg, The Next $10T Market Opportunity, and the Impact of DeepTech on Energy Costs and Climate Change (Mike Schroepfer)

Investor Stories 388: Lessons Learned (Roizen, Upham, Ho)

469. Overcoming the Odds: Pismo's Journey to Build API-First Banking, Fixing Finance's Broken Core, and the Future of Payments (Daniela Binatti)

Investor Stories 387: Why I Passed (Patil, Chase, Boduch)

OMR #460 mit Investor Christian Angermayer

Covid Vaccine Pioneer Bob Langer: Turning Science Into Billlion Dollar Ideas

Will we live longer if our dogs live longer?

DNA als Plattform der Zukunft

Trevor Martin (Mammoth Biosciences) and Ursheet Parikh (Mayfield) - Building Biotech to Last

Curing disease with CRISPR with Trevor Martin from Mammoth Biosciences

Startup Insider Daily • Recap • Fynn Kliemann • CRISPR • Turing-Test • Onecoin • Google Maps • Tesla • Apple • Ororatech

CRISPR/Cas9 mit Myopax